Literature DB >> 20697373

Gene delivery of TGF-β1 induces arthrofibrosis and chondrometaplasia of synovium in vivo.

Rachael S Watson1, Elvire Gouze, Padraic P Levings, Marsha L Bush, Jesse D Kay, Marda S Jorgensen, E Anthony Dacanay, John W Reith, Thomas W Wright, Steven C Ghivizzani.   

Abstract

To understand the cellular and molecular events contributing to arthrofibrosis, we used an adenovirus to deliver and overexpress transforming growth factor-beta 1 (TGF-β1) cDNA (Ad.TGF-β1) in the knee joints of immunocompromised rats. Following delivery, animals were killed periodically, and joint tissues were examined macroscopically and histologically. PCR-array was used to assay alterations in expression patterns of extracellular matrix (ECM)-associated genes. By days 5 and 10, TGF-β1 induced an increase in knee diameter and complete encasement of joints in dense scar-like tissue, locking joints at 90° of flexion. Histologically, massive proliferation of synovial fibroblasts was seen, followed by their differentiation into myofibroblasts. The fibrotic tissue displaced the normal architecture of the joint capsule and fused with articular cartilage. RNA expression profiles showed high levels of transcription of numerous MMPs, matricellular and ECM proteins. By day 30, the phenotype of the fibrotic tissue had undergone chondrometaplasia, indicated by cellular morphology, matrix composition and >100-fold increases in expression of collagen type II and cartilage link protein. Pre-labeling of articular cells by injection with recombinant lentivirus containing eGFP cDNA showed fibrotic/cartilaginous tissues appeared to arise almost entirely from local proliferation and differentiation of resident fibroblasts. Altogether, these results indicate that TGF-β1 is a potent inducer of arthrofibrosis, and illustrate the proliferative potential and plasticity of articular fibroblasts. They suggest the mechanisms causing arthrofibrosis share many aspects with tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697373      PMCID: PMC3724510          DOI: 10.1038/labinvest.2010.145

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  70 in total

1.  Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

Authors:  R Agnihotri; H C Crawford; H Haro; L M Matrisian; M C Havrda; L Liaw
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

2.  In vivo gene delivery to synovium by lentiviral vectors.

Authors:  Elvire Gouze; Robert Pawliuk; Carmencita Pilapil; Jean-Noel Gouze; Christina Fleet; Glyn D Palmer; Christopher H Evans; Philippe Leboulch; Steven C Ghivizzani
Journal:  Mol Ther       Date:  2002-04       Impact factor: 11.454

3.  Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose.

Authors:  Tatsuya Kobayashi; Tsutomu Inoue; Hirokazu Okada; Tomohiro Kikuta; Yoshihiko Kanno; Takashi Nishida; Masaharu Takigawa; Takeshi Sugaya; Hiromichi Suzuki
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

4.  Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.

Authors:  Yu Alice Gao; Renu Agnihotri; Calvin P H Vary; Lucy Liaw
Journal:  Matrix Biol       Date:  2004-11       Impact factor: 11.583

Review 5.  Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions.

Authors:  Anita Woods; Guoyan Wang; Frank Beier
Journal:  J Cell Physiol       Date:  2007-10       Impact factor: 6.384

6.  [Study on the directed inducing process of cartilage cells differentiated from human marrow mesenchymal stem cells].

Authors:  Xun Jiang; Pengcheng Cui; Wenxian Chen; Daqing Zhao; Jiasheng Luo; Guize Li; An Sun
Journal:  Zhonghua Er Bi Yan Hou Ke Za Zhi       Date:  2002-04

7.  Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.

Authors:  Giancarlo Castellano; Grazia Malaponte; Maria C Mazzarino; Mariangela Figini; Francesco Marchese; Pietro Gangemi; Salvatore Travali; Franca Stivala; Silvana Canevari; Massimo Libra
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

8.  Regulation of synovial cell growth. Coexpression of transforming growth factor beta and basic fibroblast growth factor by cultured synovial cells.

Authors:  D H Goddard; S L Grossman; W V Williams; D B Weiner; J L Gross; K Eidsvoog; J R Dasch
Journal:  Arthritis Rheum       Date:  1992-11

9.  Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.

Authors:  Annie Pardo; Kevin Gibson; José Cisneros; Thomas J Richards; Yinke Yang; Carina Becerril; Samueal Yousem; Iliana Herrera; Victor Ruiz; Moisés Selman; Naftali Kaminski
Journal:  PLoS Med       Date:  2005-09-06       Impact factor: 11.069

10.  Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?

Authors:  Andrew Leask; Sunil K Parapuram; Xu Shi-Wen; D J Abraham
Journal:  J Cell Commun Signal       Date:  2009-01-21       Impact factor: 5.782

View more
  25 in total

1.  Increased BMP expression in arthrofibrosis after TKA.

Authors:  Tilman Pfitzner; Sven Geissler; Georg Duda; Carsten Perka; Georg Matziolis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-17       Impact factor: 4.342

Review 2.  Adhesive capsulitis of the shoulder: review of pathophysiology and current clinical treatments.

Authors:  Hai V Le; Stella J Lee; Ara Nazarian; Edward K Rodriguez
Journal:  Shoulder Elbow       Date:  2016-11-07

Review 3.  Post-traumatic elbow stiffness: Pathogenesis and current treatments.

Authors:  Dafang Zhang; Ara Nazarian; Edward K Rodriguez
Journal:  Shoulder Elbow       Date:  2018-08-08

4.  Connective tissue growth factor (CTGF/CCN2) in haemophilic arthropathy and arthrofibrosis: a histological analysis.

Authors:  J Jiang; N L Leong; U Khalique; T M Phan; K M Lyons; J V Luck
Journal:  Haemophilia       Date:  2016-10-05       Impact factor: 4.287

5.  Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis.

Authors:  William A Blessing; Stephen M Okajima; M Belen Cubria; Juan C Villa-Camacho; Miguel Perez-Viloria; Patrick M Williamson; Angie N Sabogal; Sebastian Suarez; Lay-Hong Ang; Suzanne White; Evelyn Flynn; Edward K Rodriguez; Mark W Grinstaff; Ara Nazarian
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-03       Impact factor: 11.205

6.  Anti-inflammatory Drug Dexamethasone Treatment During the Remobilization Period Improves Range of Motion in a Rat Knee Model of Joint Contracture.

Authors:  Akinori Kaneguchi; Junya Ozawa; Kaoru Yamaoka
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

7.  Joint contracture is reduced by intra-articular implantation of rosiglitazone-loaded hydrogels in a rabbit model of arthrofibrosis.

Authors:  Diren Arsoy; Christopher G Salib; William H Trousdale; Meagan E Tibbo; Afton K Limberg; Anthony Viste; Eric A Lewallen; Nicolas Reina; Michael J Yaszemski; Daniel J Berry; Andre J van Wijnen; Mark E Morrey; Joaquin Sanchez-Sotelo; Matthew P Abdel
Journal:  J Orthop Res       Date:  2018-07-13       Impact factor: 3.494

8.  Postoperative Serum Cytokine Levels Are Associated With Early Stiffness After Total Knee Arthroplasty: A Prospective Cohort Study.

Authors:  Michael-Alexander Malahias; George A Birch; Haoyan Zhong; Alexandra Sideris; Alejandro Gonzalez Della Valle; Peter K Sculco; Meghan Kirksey
Journal:  J Arthroplasty       Date:  2020-02-28       Impact factor: 4.757

9.  No effect of subperiosteal growth factor application on periosteal neo-chondrogenesis in osteoperiosteal bone grafts for osteochondral defect repair.

Authors:  Tobias Gotterbarm; Steffen J Breusch; Simona Berardi Vilei; Pierre Mainil-Varlet; Wiltrud Richter; Martin Jung
Journal:  Int Orthop       Date:  2013-03-17       Impact factor: 3.075

10.  Early response of mouse joint tissue to noninvasive knee injury suggests treatment targets.

Authors:  P Wu; N Holguin; M J Silva; M Fu; W Liao; L J Sandell
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.